EntryPoint Capital »

Intellia Therapeutics shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $378k 32k 11.66
2024-06-30 $7.2k 322 22.38